等待開盤 11-18 09:30:00 美东时间
0.000
0.00%
Corbus Pharmaceuticals reported key milestones in Q3 2026, including initiating dosing in the TEMPO-1 registrational study for sutantatug envedotin in oropharyngeal cancer and announcing positive topline data for CRB-913 in obesity, showing a 5% weight loss at 12 weeks with favorable safety. The company also appointed a new Chief Medical Officer and reported a net loss of $37.8 million, with $115.3 million in cash on hand.
11-10 13:00
Tempsens Instruments (India) Limited ( ($IN:TEMPSENS) ) has provided an announc...
10-30 23:43
Fluke introduces new refrigerated calibration baths (7508, 7511, 7512) designed for high-accuracy temperature sensor testing. These baths offer exceptional stability (±0.0007°C) and uniformity (±0.003°C), reducing temperature variability and measurement uncertainty. They automate calibration tasks, support multiple sensor types, and simplify maintenance with features like direct-drive stirrers and CFC-free refrigerants. Ideal for metrology labs, ...
10-28 07:30
Tempus Capital ( ($TSE:TEMP) ) has shared an update. Tempus Capital Inc. has ag...
10-02 02:49
The U.S. Food and Drug Administration (FDA) has approved AbbVie’s (ABBV) Juvmo (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for treating adults with Parkinson’s disease. ...
09-28 20:19
The latest announcement is out from Tempsens Instruments (India) Limited ( ($IN...
09-13 17:52
比特币的未来走向取决于能否选出保护核心功能的协议提案,并在紧急情况出现前取得各方一致同意,这是继早期硬分叉争议之后,比特币社区面临的又一次严峻治理考验。
08-03 17:20
The US FDA has chosen Dexcom (DXCM) as the first participant in its Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program. The continuous glucose monitor maker said it would "implement...
07-23 05:39